The U.S. hysteroscopy procedures market , valued at USD 4.12 billion in 2025, is projected to reach approximately USD 6.4 billion by 2035, growing at a CAGR of 4.50%, driven by increasing adoption of minimally invasive surgeries and advancements in diagnostic technologies.

U.S. Hysteroscopy Procedures Market Statical Scope

The growing demand for minimally invasive gynaecological procedures and outpatient office-based procedures helps to fuel the growth of the market.

The U.S. hysteroscopy procedures market is also observed to grow due to the growing prevalence of uterine issues in the region, such as abnormal bleeding, uterine fibroids, fertility issues, and various other gynecological issues. Growing demand for outpatient facilities and office-based care for quicker recovery and lower hospital stays also helps to fuel the growth of the market. Increased usage of hysteroscopy for diagnostic evaluation related to infertility also helps propel the growth of the market.

U.S. Hysteroscopy Procedures Market Share, By Procedure, 2025 (%)

• Diagnostic Hysteroscopy- The segment dominated the growth of the market with 28% of the market share in 2025. The segment's growth is mainly driven by higher demand for minimally invasive procedures to detect uterine abnormalities and to detect infertility.
• Polypectomy/Targeted Biopsy- The segment accounts for 18% of the market share and is mainly driven by the growing prevalence of endometrial polyps and the growing demand for tissue diagnostics procedures.
• Myomectomy- The segment holds 16% of the market share and is majorly driven by gynecological procedures helpful to enhance the chances of fertility and growing demand for minimally invasive procedures.
• Endometrial Ablation- The segment accounts for 14% of the market share and is majorly driven by patients suffering from gynecological issues such as abnormal bleeding and various other issues.

U.S. Hysteroscopy Procedures Market Share, By End Use, 2025 (%)

• Hospitals- The segment dominated the global market with 52% of the market share in 2025 and is driven by factors such as advanced healthcare infrastructure and availability of healthcare professionals to treat complicated gynecological issues.
• Clinics- The segment holds 30% of the market share and is driven by factors such as growing demand for outpatient facilities and quicker recovery times.
• Ambulatory Surgery Clinics- The segment has a significant share of 18% and is driven by factors such as growing demand for outpatient facilities, lower traditional hospital stays, same-day discharge, and quicker recovery.

Competitive Landscape

The U.S. hysteroscopy procedures market is majorly driven by firms such as Delmont Imaging, MedGyn Products Inc., LiNA Medical ApS, and Boston Scientific Corporation. The main aim of such companies is to focus on high-definition visualization systems along with minimally invasive and outpatient instruments to meet the growing demand of patients in the region. Such companies also focus on technological advancements in the form of advanced therapeutic tools, advanced visualization, and hysteroscopic camera systems, which are helpful to fuel the market's growth.

Recent Developments in the Market

In November 2025, UroViu Corporation announced that it had received CE certification for its cystoscope and hysteroscope product portfolio. This includes the reusable UV5000w Wi-Fi Handle and the disposable Hystero-V, Uro-V, and Uro-GHD endoscopes.

Segments Covered in the Report

By Procedure

• Diagnostic Hysteroscopy
• Polypectomy / Targeted Biopsy
• IUD / Foreign Body Removal
• Tubal Cannulation / Recanalization
• Myomectomy
• Endometrial Ablation
• Other

By End Use

• Hospitals
• Clinics
• Ambulatory Surgery Centers